Shilpa Medicare Limited (SHILPAMED) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.083x

Based on the latest financial reports, Shilpa Medicare Limited (SHILPAMED) has a cash flow conversion efficiency ratio of 0.083x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.01 Billion ≈ $21.76 Million USD) by net assets (Rs24.39 Billion ≈ $263.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Shilpa Medicare Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Shilpa Medicare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read SHILPAMED liabilities breakdown for a breakdown of total debt and financial obligations.

Shilpa Medicare Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shilpa Medicare Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Quidel Corporation NASDAQ:QDEL	0.069x
Gryphon Capital Income Trust AU:GCI	-0.161x
Imperial Metals Corporation TO:III	0.073x
Shenyu Communication Technology Inc SHE:300563	0.029x
Bergman & Beving AB (publ) ST:BERG-B	0.065x
GL Events SA PA:GLO	0.162x
Sinosteel Luonai Materials Technology Co. Ltd. A SHG:688119	N/A
Shanghai Shuixing Home Textile Co Ltd Class A SHG:603365	0.000x

Annual Cash Flow Conversion Efficiency for Shilpa Medicare Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Shilpa Medicare Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Shilpa Medicare Limited.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs23.64 Billion ≈ $255.63 Million	Rs1.32 Billion ≈ $14.29 Million	0.056x	-26.35%
2024-03-31	Rs18.00 Billion ≈ $194.66 Million	Rs1.37 Billion ≈ $14.78 Million	0.076x	-40.43%
2023-03-31	Rs17.74 Billion ≈ $191.89 Million	Rs2.26 Billion ≈ $24.46 Million	0.127x	+119.59%
2022-03-31	Rs18.11 Billion ≈ $195.87 Million	Rs1.05 Billion ≈ $11.37 Million	0.058x	+81.52%
2021-03-31	Rs14.67 Billion ≈ $158.70 Million	Rs469.28 Million ≈ $5.08 Million	0.032x	-65.85%
2020-03-31	Rs13.21 Billion ≈ $142.91 Million	Rs1.24 Billion ≈ $13.38 Million	0.094x	-24.09%
2019-03-31	Rs11.90 Billion ≈ $128.69 Million	Rs1.47 Billion ≈ $15.87 Million	0.123x	+196.51%
2018-03-31	Rs10.80 Billion ≈ $116.78 Million	Rs449.20 Million ≈ $4.86 Million	0.042x	+1.43%
2017-03-31	Rs9.14 Billion ≈ $98.83 Million	Rs374.77 Million ≈ $4.05 Million	0.041x	-77.31%
2016-03-31	Rs7.12 Billion ≈ $77.01 Million	Rs1.29 Billion ≈ $13.92 Million	0.181x	+47.44%
2015-03-31	Rs5.61 Billion ≈ $60.71 Million	Rs688.06 Million ≈ $7.44 Million	0.123x	-28.87%
2014-03-31	Rs4.06 Billion ≈ $43.96 Million	Rs700.41 Million ≈ $7.57 Million	0.172x	+29.97%
2013-03-31	Rs3.29 Billion ≈ $35.60 Million	Rs436.38 Million ≈ $4.72 Million	0.133x	-30.71%
2012-03-31	Rs2.81 Billion ≈ $30.37 Million	Rs537.36 Million ≈ $5.81 Million	0.191x	+5.31%
2011-03-31	Rs2.35 Billion ≈ $25.36 Million	Rs426.13 Million ≈ $4.61 Million	0.182x	-65.62%
2010-03-31	Rs1.01 Billion ≈ $10.95 Million	Rs535.22 Million ≈ $5.79 Million	0.528x	+4.69%
2009-03-31	Rs589.21 Million ≈ $6.37 Million	Rs297.43 Million ≈ $3.22 Million	0.505x	+307.88%
2008-03-31	Rs560.02 Million ≈ $6.06 Million	Rs69.31 Million ≈ $749.54K	0.124x	-39.79%
2007-03-31	Rs418.09 Million ≈ $4.52 Million	Rs85.93 Million ≈ $929.33K	0.206x	+203.23%
2006-03-31	Rs350.17 Million ≈ $3.79 Million	Rs-69.72 Million ≈ $-753.98K	-0.199x	--

About Shilpa Medicare Limited

NSE:SHILPAMED India Drug Manufacturers - Specialty & Generic

Market Cap

$860.12 Million

Rs79.53 Billion INR

Market Cap Rank

#9808 Global

#461 in India

Share Price

Rs406.65

Change (1 day)

+0.64%

52-Week Range

Rs267.00 - Rs985.80

All Time High

Rs985.80